In the News
Axiom Brain Health Welcomes Next Research Leader and Celebrates a Legacy of Neurological Research and Innovation
Axiom Brain Health (Axiom) a Global Alzheimer’s Platform Foundation ® (GAP) owned and operated site, is celebrating the next chapter in neurodegenerative research as Dr. Jeffrey Greenberg joins the team as Medical Director and Principal Investigator. This new leadership will drive continued momentum in the fight against Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, dementia with Lewy bodies and other […]
Global Alzheimer’s Platform Foundation Names New Medical Director at Tampa Research Site
The Global Alzheimer’s Platform Foundation® (GAP), announced today that Dr. Jeffery Greenberg is joining GAP as the Medical Director and Principal Investigator of Axiom Brain Health (Axiom), GAP’s clinical research site in Tampa, FL. Dr. Greenberg succeeds Dr. Susan Steen, Axiom’s longtime Medical Director and a Tampa Practitioner, who will retire at the end of the year. […]
Psychiatric Times: Biomarker Testing for Alzheimer Disease: Inside the Latest P-Tau217 Data
Key Takeaways Plasma P-tau217 blood tests match amyloid PET for early Alzheimer pathology, offering scalable, noninvasive detection and forecasting cognitive decline risk years ahead. Blood-based biomarker testing for Alzheimer disease pathology continues to advance, with recent data evaluating the rule-in performance of plasma phosphorylated tau 217 (P-tau217) blood tests for identifying cognitively unimpaired individuals with […]
GAP Statement on FDA clearance for Elecsys® pTau217
We applaud the FDA’s clearance for Elecsys® Phospho-Tau (217P) Plasma (pTau217) blood test another important milestone that has the potential to advance the Alzheimer’s diagnostic process and bring more accessible, scalable tools to physicians and specialists, ultimately benefitting people living with Alzheimer’s disease. Developed as a collaboration between Eli Lilly & Co and Roche, Elecsys® […]
TakeToNews: Is the p-tau217 Test the Key to Predicting 78% Cognitive Decline Risk?
The landscape of Alzheimer’s diagnostics is undergoing a significant transformation. Recent clinical studies and reports from mid-2026 confirm the increasing reliability of blood biomarkers in identifying Alzheimer-related pathologies. These blood tests enable a more precise and earlier diagnosis compared to traditional methods, suggesting that blood tests could play a central role in clinical routines and […]
Bio-Hermes-002 Completes Enrollment Marking Milestone for Innovative Alzheimer’s Study Advancing Early Detection
The Global Alzheimer’s Platform Foundation enrolled 1,000+ participants with unprecedented 27% from traditionally understudied populations Washington D.C., August 11, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) has reached full enrollment for the innovative Bio-Hermes-002 Study, successfully recruiting more than 1,000 participants. The milestone marks an important step toward advancing the next generation of blood and digital biomarker […]
Statement on the Cancellation of NIH Alzheimer’s Research Grants
The cancellation of ongoing NIH-funded Alzheimer’s research grants is a serious setback in the fight against Alzheimer’s disease. Halting peer-reviewed studies wastes taxpayer investments, disrupts years of scientific progress, and delays the discoveries that millions of patients and families urgently need. Alzheimer’s disease is one of our nation’s greatest public health challenges. Progress depends on […]
NeurologyLive: The Study Design Behind P-tau217 Rule-In Performance
August 3, 2026Author(s)Yogesh Shah, MD, MPH, FAAFP Dr. Yogesh Shah, MD, reviews the evidence supporting P-tau217 as a reliable rule-in biomarker for Alzheimer’s pathology and discusses how clinicians can incorporate blood-based testing into patient evaluation.As blood-based biomarkers move closer to routine clinical use, demonstrating agreement with established diagnostic standards remains essential. For Alzheimer disease (AD), […]
Central Florida Public Media: Central Florida seniors learned practical ways to support cognitive wellness through exercise, social engagement, and learning.
Residents of the College Park Towers Senior Apartments in Orlando gathered Wednesday for Bilingual Activ8 Your Brain Bingo, an event designed to promote brain health through fun, interactive activities. The nonprofit Global Alzheimer’s Platform Foundation partnered with Conquest Research to offer brain health education and free cognitive screenings. Engage speaks with participants and organizers about simple habits that can help […]
ALZForum: PrevenTRON and Beyond
24 Jul 2026 Part 2 of 2No, they are not Optimus Jr, Megatron’s clones, or any other new, amyloid-shattering members of the Tron family franchise of transformer robots, though perhaps Roche does not mind if you think so for a moment. Rather, the TRONTIER twins are currently enrolling Phase 3 trials for early AD, and […]